Bi-phenotypic T(9;22)-positive Leukemia Cell Lines from a Patient with Acute Leukemia: NALM-20, Established at the Onset; and NALM-21, NALM-22 and NALM-23, Established After Relapse
Overview
Authors
Affiliations
Four leukemia cell lines; NALM-20, established at the onset of leukemia and NALM-21, -22 and -23 established at the relapse of the disease were found to be t(9;22)-positive leukemia lines having the biphenotypic feature of B cell and myeloid cell characteristics. In addition, a polyclonal Epstein-Barr virus-transformed normal B cell line, B250, was established from the peripheral blood at the onset of the disease.
Quentmeier H, Pommerenke C, Drexler H Curr Issues Mol Biol. 2021; 43(3):2147-2156.
PMID: 34940123 PMC: 8929001. DOI: 10.3390/cimb43030149.
KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia.
Zhang C, DAlessandro A, Wellendorf A, Mohmoud F, Serrano-Lopez J, Perentesis J Oncotarget. 2018; 9(51):29665-29679.
PMID: 30038712 PMC: 6049869. DOI: 10.18632/oncotarget.25667.
Guillaumet-Adkins A, Richter J, Odero M, Sandoval J, Agirre X, Catala A J Hematol Oncol. 2014; 7:4.
PMID: 24405639 PMC: 3900738. DOI: 10.1186/1756-8722-7-4.
Kaneko H, Ariyasu T, Inoue R, Fukao T, Kasahara K, Teramoto T Clin Exp Immunol. 1998; 111(2):339-44.
PMID: 9486401 PMC: 1904901. DOI: 10.1046/j.1365-2249.1998.00509.x.